A fundamental role for NO-PLC signaling pathway in mediating intracellular Ca2+ oscillation in pancreatic acini

Nitric Oxide. 2011 Apr 30;24(3):139-50. doi: 10.1016/j.niox.2011.02.001. Epub 2011 Feb 16.

Abstract

The aim of the present study was to investigate the possible interaction between intracellular Ca(2+) and nitric oxide (NO) in rat pancreatic acinar cells, especially intracellular signaling events. (1) Nitric oxide donors SNP (0.1-100 μM) and NOR-3 (50-400 μM) induced Ca(2+) oscillations in fluo-4-loaded acini, that appeared to be analogous to what we usually observe in acini stimulated with physiological secretagogues such as CCK-8 and this oscillations were abolished in the presence of carboxy-PTIO. (2) The NO donors-evoked Ca(2+) oscillations were not abolished even in the absence of extracellular Ca(2+) but totally disappeared when cells were pretreated with thapsigargin, a sarcoplasmic-endoplasmic reticulum Ca(2+) ATPase (SERCA) inhibitor. (3) Inhibition of guanylate cyclase with 1 H-[1,2,4] oxadiazolo [4,3-a] quinoxaline-1-one (ODQ) attenuated Ca(2+) oscillations evoked by SNP in the absence of extracellular Ca(2+). (4) Inhibitors of phospholipase C activity, U73122 and the IP(3)R blocker xestospongin C, both abolished the SNP-induced Ca(2+) response. (5) Furthermore, we found that both CCK-8 and carbachol (CCh) induced NO production in DAF-2-loaded acinar cells and that an inhibitor of NO synthase, N(G)-monomethyl-l-arginine (L-NMMA), significantly reduced CCK-8-induced Ca(2+) oscillation. These results indicate that NO mobilizes Ca(2+) from internal stores through activation of guanylate cyclase and resultant cGMP production. In addition, PLC activation of IP(3) production is also suggested to be involved in Ca(2+) mobilization via IP(3) receptors. This suggests the presence of cross-talk between Ca(2+) and NO in pancreatic acini and this cascade may, at least partially, participate in physiological secretagogue-evoked Ca(2+) dynamics in pancreatic acinar cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism*
  • Carcinoma, Acinar Cell / metabolism*
  • Estrenes / pharmacology
  • Inositol 1,4,5-Trisphosphate / antagonists & inhibitors
  • Inositol 1,4,5-Trisphosphate / metabolism
  • Macrocyclic Compounds / pharmacology
  • Male
  • Nitric Oxide / metabolism*
  • Nitric Oxide Donors / pharmacology
  • Nitroprusside / pharmacology
  • Oxadiazoles / pharmacology
  • Oxazoles / pharmacology
  • Pancreatic Neoplasms / metabolism*
  • Phosphodiesterase Inhibitors / pharmacology
  • Pyrrolidinones / pharmacology
  • Quinoxalines / pharmacology
  • Rats
  • Rats, Wistar
  • Signal Transduction / drug effects
  • Sincalide / metabolism
  • Type C Phospholipases / antagonists & inhibitors
  • Type C Phospholipases / metabolism*

Substances

  • 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
  • Estrenes
  • Macrocyclic Compounds
  • Nitric Oxide Donors
  • Oxadiazoles
  • Oxazoles
  • Phosphodiesterase Inhibitors
  • Pyrrolidinones
  • Quinoxalines
  • xestospongin C
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • Nitroprusside
  • Nitric Oxide
  • Inositol 1,4,5-Trisphosphate
  • Type C Phospholipases
  • Sincalide
  • Calcium